(Q33375798)

English

High anti-lymphoma activity of bendamustine/mitoxantrone/rituximab in rituximab pretreated relapsed or refractory indolent lymphomas and mantle cell lymphomas. A multicenter phase II study of the German Low Grade Lymphoma Study Group (GLSG).

scientific article

Statements

High anti-lymphoma activity of bendamustine/mitoxantrone/rituximab in rituximab pretreated relapsed or refractory indolent lymphomas and mantle cell lymphomas. A multicenter phase II study of the German Low Grade Lymphoma Study Group (GLSG). (English)
Rudolf Weide
Hubert Köppler
Jochen Heymanns
Jörg Thomalla
Christoph Losem
Stefan Schmitz
Christoph Huber
Michael Unterhalt
Martin Dreyling
German Low Grade Lymphoma Study Group
1299-1306

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit